In the framework of the assessment of the condition laid down in Article 6(3), point (b) of the IPI Regulation about the ‘availability of alternative sources of supply for the goods […] concerned, in order to avoid or minimise a significant negative impact on contracting authorities and contracting entities’, the Commission consulted Member States in the Trade Barriers Committee to ascertain that there are no dependencies of Members States on medical devices originating in the PRC.
11 1. PROCEDURE › 1.3. Subsequent procedure › 1.3.2. Information to Member States, Regulation (EU) 2025/1197
In forcesince 19 Jun 2025